Literature DB >> 33211079

Regarding Use of Topical Steroids in Patients With COVID-19-Associated Olfactory Loss-Reply.

Joshua M Levy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33211079      PMCID： PMC8027905          DOI： 10.1001/jamaoto.2020.4276

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN： 2168-6181            Impact factor:   6.223


× No keyword cloud information.
  6 in total

1.  Anosmia and loss of smell in the era of covid-19.

Authors:  Abigail Walker; Gillian Pottinger; Andrew Scott; Claire Hopkins
Journal:  BMJ       Date:  2020-07-21

Review 2.  Olfactory Dysfunction in COVID-19: Diagnosis and Management.

Authors:  Katherine Lisa Whitcroft; Thomas Hummel
Journal:  JAMA       Date:  2020-06-23       Impact factor: 56.272

3.  EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps.

Authors:  M R Sher; G C Steven; J L Romett; G Pien; K LeBenger; J C Messina; J L Carothers; R A Mahmoud; P G Djupesland
Journal:  Rhinology       Date:  2020-02-01       Impact factor: 3.681

4.  Therapeutic use of steroids in non-chronic rhinosinusitis olfactory dysfunction: a systematic evidence-based review with recommendations.

Authors:  Carol H Yan; Jonathan B Overdevest; Zara M Patel
Journal:  Int Forum Allergy Rhinol       Date:  2018-11-24       Impact factor: 3.858

5.  Treatment Recommendations for Persistent Smell and Taste Dysfunction Following COVID-19-The Coming Deluge.

Authors:  Joshua M Levy
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-08-01       Impact factor: 6.223

6.  Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss.

Authors:  Teresa P Nguyen; Zara M Patel
Journal:  Int Forum Allergy Rhinol       Date:  2018-06-14       Impact factor: 3.858
  6 in total
  5 in total

1.  Treatment strategies for postviral olfactory dysfunction: A systematic review.

Authors:  Samuel N Helman; Jonah Adler; Aria Jafari; Sasha Bennett; Jackson R Vuncannon; Ashley C Cozart; Sarah K Wise; Merin E Kuruvilla; Joshua M Levy
Journal:  Allergy Asthma Proc       Date:  2022-03-01       Impact factor: 2.587

Review 2.  Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.

Authors:  Katie E Webster; Lisa O'Byrne; Samuel MacKeith; Carl Philpott; Claire Hopkins; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2022-09-05

Review 3.  Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.

Authors:  Lisa O'Byrne; Katie E Webster; Samuel MacKeith; Carl Philpott; Claire Hopkins; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2022-09-05

4.  Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.

Authors:  Katie E Webster; Lisa O'Byrne; Samuel MacKeith; Carl Philpott; Claire Hopkins; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2021-07-22

5.  Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.

Authors:  Lisa O'Byrne; Katie E Webster; Samuel MacKeith; Carl Philpott; Claire Hopkins; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2021-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.